The leukapheresis market in North America is expected to grow from US$ 28.54 million in 2021 to US$ 52.65 million by 2028; it is estimated to grow at a CAGR of 9.1% from 2021 to 2028.
Blood diseases disturb the overall well-being of patients. Anemia; hemophilia; von Willebrand disease (VWD); blood cancers such as myeloma, leukemia, and lymphoma are among the common blood diseases. The number of newly diagnosed leukemia cases increased from 354,500 in 1990 to 518,500 in 2017. In the US, the estimated number of people living with leukemia or are in remission from leukemia totals ~376,508. Leukemia was the sixth most common cause of cancer-related deaths in both men and women in the US during 2012–2016. In 2020, ~23,100 people are expected to die from leukemia (13,420 males and 9,680 females). Further, according to the National Heart, Lung, and Blood Institute, anemia affects more than 3 million Americans every year, while as per the WHO, it affects ~1.62 billion people worldwide. According to the Centers of Disease Control and Prevention (CDC), hemophilia A affects ~1 in 5,000 male births. The CDC survey for 2017 reported that Von Willebrand disease (VWD), one of the most commonly occurring bleeding disorders, affects up to 1% of the population. More than 14,600 men, women, and children were seen at hemophilia treatment centers for the treatment of VWD during 2012–2016. The rising incidence of these diseases maximizes the need for blood transfusion, thereby bolstering the demand for leukapheresis equipment. Two of the most common types of apheresis used for the removal of harmful substances from blood are cytapheresis and plasma exchange. Plasma exchange is used to treat disorders such as myasthenia gravis, thrombotic thrombocytopenic purpura, and multiple sclerosis. Cytapheresis, a process that removes the excess number of blood cells, is used in the treatment of leukemia, polycythemia, and thrombocythemia, among others.North America has been witnessing a growing number of COVID-19 cases since its outbreak. The cases are also increasing in Mexico. In Mexico. At present, the majority of the diagnostic laboratories and research institutes are engaged in diagnosing the COVID-19 patients. Currently, the COVID-19 diagnostic testing industry is witnessing upsurge on account of a growing number of cases coupled with the increasing emergency use authorizations from the regulatory bodies. In addition, With the WHO declaring the COVID-19 outbreak a pandemic, a mix of established pharmaceutical and biopharmaceutical companies and small startups have stepped forward to develop treatments that target the infection. The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. The FDA issued this emergency use authorization to Terumo BCT Inc. and Marker Therapeutics AG for their Spectra Optia Apheresis System and Depuro D2000 Adsorption Cartridge devices.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America leukapheresis market. The North America leukapheresis market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Leukapheresis Market Segmentation
North America Leukapheresis Market – By Product Type
- Leukapheresis Disposables
- Leukapheresis Devices
North America Leukapheresis Market – By Application
- Research Applications
- Therapeutic Applications
North America Leukapheresis Market – By Product Type
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
North America Leukapheresis Market – By Country
- US
- Canada
- Mexico
North America Leukapheresis Market – Companies Mentioned
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
North America Leukapheresis Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 28.54 Million |
Market Size by 2028 | US$ 52.65 Million |
Global CAGR (2021 - 2028) | 9.1% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT


